GB1023715A - New 7ª‡-methyl-androstenes and process for their manufacture - Google Patents

New 7ª‡-methyl-androstenes and process for their manufacture

Info

Publication number
GB1023715A
GB1023715A GB15141/64A GB1514164A GB1023715A GB 1023715 A GB1023715 A GB 1023715A GB 15141/64 A GB15141/64 A GB 15141/64A GB 1514164 A GB1514164 A GB 1514164A GB 1023715 A GB1023715 A GB 1023715A
Authority
GB
United Kingdom
Prior art keywords
methyl
unsubstituted
oxo
steroid
androstenes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB15141/64A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Schweiz AG
Original Assignee
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba AG filed Critical Ciba AG
Publication of GB1023715A publication Critical patent/GB1023715A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
GB15141/64A 1963-05-17 1964-04-13 New 7ª‡-methyl-androstenes and process for their manufacture Expired GB1023715A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH627863A CH429715A (de) 1963-05-17 1963-05-17 Verfahren zur Herstellung neuer 4-Halogen-androstene
CH627763A CH442294A (de) 1963-05-17 1963-05-17 Verfahren zur Herstellung neuer 7a-Methyl-androstene
CH299264 1964-03-09
CH299164 1964-03-09

Publications (1)

Publication Number Publication Date
GB1023715A true GB1023715A (en) 1966-03-23

Family

ID=27428548

Family Applications (2)

Application Number Title Priority Date Filing Date
GB15142/64A Expired GB1023798A (en) 1963-05-17 1964-04-13 New 4-halogen-androstenes
GB15141/64A Expired GB1023715A (en) 1963-05-17 1964-04-13 New 7ª‡-methyl-androstenes and process for their manufacture

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB15142/64A Expired GB1023798A (en) 1963-05-17 1964-04-13 New 4-halogen-androstenes

Country Status (9)

Country Link
US (2) US3299105A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (2) BE648014A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BR6459217D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (2) CH429715A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE1443638C3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (4) FR3791M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (2) GB1023798A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL6405463A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (2) SE323670B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6576M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1965-10-11 1968-12-30
US3405128A (en) * 1966-07-11 1968-10-08 Searle & Co 18-alkylated-17alpha-(2-alkynyl)estra-1, 3, 5(10)-triene-3, 17beta-diols, ethers andesters thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060201A (en) * 1958-06-06 1962-10-23 Farmaceutici Italia 4-hydroxy-17alpha-methyl-3-keto-delta-steroids of androstane and 19-nor-androstane series and esters thereof
US3074932A (en) * 1960-08-15 1963-01-22 American Cyanamid Co 7-substituted thio steroids
GB922802A (en) * 1960-08-11 1963-04-03 Farmaceutici Italia A process for the preparation of 4-acyloxy-and 4-hydroxy-3-keto-í¸-steroids

Also Published As

Publication number Publication date
FR3805M (fr) 1966-01-03
CH442294A (de) 1967-08-31
BR6459217D0 (pt) 1973-08-09
FR3982M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1966-03-07
GB1023798A (en) 1966-03-23
CH429715A (de) 1967-02-15
DE1443638B2 (de) 1973-06-20
FR3791M (fr) 1965-12-27
US3299105A (en) 1967-01-17
FR3981M (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1966-03-07
US3359261A (en) 1967-12-19
DE1443637A1 (de) 1969-10-23
SE333141B (sv) 1971-03-08
NL6405463A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1964-11-18
BE648013A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE648014A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE1443638A1 (de) 1968-11-21
DE1443638C3 (de) 1974-01-24
SE323670B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1970-05-11

Similar Documents

Publication Publication Date Title
GB1087319A (en) 17ª‡-methyl-estradiols and process for their manufacture
GB1023715A (en) New 7ª‡-methyl-androstenes and process for their manufacture
GB1058543A (en) 16-methylene-steroids
DE1568307A1 (de) Verfahren zur Herstellung neuer 19-Norandrostatriene
ES322296A1 (es) Procedimiento catalitico para la preparacion de compuestos alquilaromaticos.
GB1074491A (en) Novel processes for preparing steroid compounds, the compounds when thus prepared, novel steroid compounds thereby prepared, and pharmaceutical compositions containing the novel compounds
GB937410A (en) Improvements in or relating to steroids and the manufacture thereof
ES297078A1 (es) Procedimiento para la obtenciën de compuestos esteroides
GB1029439A (en) í¸-3-hydroxy-steroids and derivatives thereof
GB1027269A (en) New methyl-androstenes and process for their manufacture
GB1045035A (en) 1ª‡-methyl-í¸-5ª‡-androsten-17ª‰-ols and a process for their manufacture
GB1027268A (en) New methyl-androstenes and process for their manufacture
GB969434A (en) New 3-methylene-steroids and processes for their manufacture
GB1206816A (en) Novel 4-oxa steroids, processes for their preparation and conversion into other steroids, and the steroids thus produced
GB1094390A (en) Preparation of í¸-pregnatriene compounds
ES338729A1 (es) Procedimiento de preparacion de 15, 16beta-metilenesteroi- des de la serie 19-nor-androstan.
GB1145063A (en) Improvements in or relating to novel steroids and the manufacture thereof
GB979891A (en) Process for the production of new steroid compounds
FI52100C (fi) Menetelmä uudien pregnaanisarjaan kuuluvien, tulehduksenvastaisten 21- asemassa alkyloitujen steroidien valmistamiseksi.
GB996079A (en) 17ª‡,21-substituted methylenedioxy steroids and methods therefor
GB979037A (en) New 6-alkyl-steroids
GB969300A (en) New steroids of the androstane series and process for their production
ES295478A1 (es) Procedimiento para la preparacion de 17alfa-alcoxi-esteroides
GB1067345A (en) Novel steroid compounds, processes for preparing them and compositions containing them
GB1019455A (en) í¸-3-keto-androstadiene compounds and process for their manufacture